Patents
Patents for C07H 21 - Compounds containing two or more mononucleotide units having separate phosphate or polyphosphate groups linked by saccharide radicals of nucleoside groups, e.g. nucleic acids (89,892)
01/2009
01/29/2009US20090029420 solubility tag characterized by an increase in acid resistance; production and recovery of fusion peptide; inclusion body tag's resistance to acid hydrolysis facilitates easier and cleaner separation of the peptide of interest after acid hydrolysis
01/29/2009US20090029380 HUMAN MutY
01/29/2009US20090029376 High Fidelity Restriction Endonucleases
01/29/2009US20090029371 Method for determining vasoreactivity
01/29/2009US20090029370 Real time nucleic acid detection in vivo using protein complementation
01/29/2009US20090029363 Method of selection by two-dimensional separation, of nucleic acids that bind to a target with high affinity
01/29/2009US20090029361 Growth differentiation factor-7
01/29/2009US20090029359 Diagnostic methods for early cancer detection
01/29/2009US20090029358 Methods and Compositions for the Diagnosis and Treatment of Schizophrenia
01/29/2009US20090029356 Corynebacterium glutamicum genes encoding novel proteins
01/29/2009US20090029354 designing a RNA jamming sequence, named DSG3-RNAi, synthesizing two clones of DSG3-RNAi having specific nuclic acid sequences, linking these sequences into an expression vector and making a plasmid, transfecting the plasmid into cancer individuals respectively for inhibiting cell growth of cancer
01/29/2009US20090029001 Gene encoding protein responsible for flocculation property of yeast and use thereof
01/29/2009US20090028880 Serum albumin binding proteins
01/29/2009US20090028863 Markers for diagnosis of cancer and its use
01/29/2009US20090028861 Cancer cell-specific apoptosis-inducing agents that target chromosome stabilization-associated genes
01/29/2009US20090028843 IgA allelic variants
01/29/2009US20090028784 Antibodies to IL-6 and use thereof
01/29/2009US20090026082 Methods and apparatus for measuring analytes using large scale FET arrays
01/29/2009DE102007035250A1 Verfahren zum Abtrennen von nicht-proteinhaltigen Biomolekülen, insbesondere Nukleinsäuren aus proteinhaltigen Proben A method for separating non-proteinaceous biomolecules, in particular nucleic acids from protein-containing samples
01/29/2009CA2692161A1 Stabilized immune modulatory rna (simra) compounds
01/28/2009EP2019115A2 Pesticidally active proteins and polynucleotides obtainable from paenibacillus species
01/28/2009EP2018395A1 Short interference ribonucleic acids for treating allegic diseases
01/28/2009EP1856261A4 Method for preparing transformants expressing benzaldehyde dehydrogenase and prepation of 2,6-naphthalene dicarboxylic acid using the transformants
01/28/2009EP1207755B1 Use of a ribonuclease of the T2 family having actin-binding activity for inhibiting and/or reversing proliferation
01/28/2009EP0675953B1 Soluble peptides having constrained, secondary conformation in solution and method of making same
01/28/2009CN101356269A Methods for expression and purification of recombinant human growth hormone
01/28/2009CN101356192A Compositions and methods for modulating hemostasis
01/28/2009CN101356184A Methods for assessing patients with acute myeloid leukemia
01/28/2009CN101353656A siRNA inhibiting expression of epidermal growth factor receptor genes and use thereof
01/28/2009CN101353655A siRNA inhibiting expression of vascular endothelial growth factor receptor genes and use thereof
01/28/2009CN101353364A Method for obtaining small RNA from murine brain
01/28/2009CN101353345A Polyamine and polyamide conjugates and preparation thereof
01/28/2009CN100455669C Microorganisms and processes for enhanced production of pantothenate
01/27/2009US7482444 Nucleoside 5'-triphosphates or their acylic analogues labeled with luminescent or non-luminescent lanthanide(III) chelates to serve as terminating substrates; sequencing DNA
01/27/2009US7482443 Systems and methods to quantify and amplify both signaling probes for cDNA chips and genes expression microarrays
01/27/2009US7482442 HEMCM42 nucleic acids
01/27/2009US7482441 Artificial chromosomes comprising EHV sequences
01/27/2009US7482440 Hemopoietin receptor protein, NR10
01/27/2009US7482432 Protein for use as tool in controlling plant pest; pesticides; biological pest control; moths and beetles
01/27/2009US7482427 Synthetic peptides having a non growth factor heparin binding region, a linker, and sequences; treatment of bone lesions, degenerative joint disease and to enhance bone formation
01/27/2009US7482331 Treating myocardial failure in a human by administering an effective amount of a transgene encoding for alpha-MHC, wherein expression of alpha-MHC provides improvement in left ventricular ejection fraction
01/27/2009US7482158 Composite polynucleic acid therapeutics
01/27/2009US7482157 Monacolin K biosynthesis genes
01/27/2009US7482156 Hepatocellular carcinoma specific promoter and uses thereof
01/27/2009US7482155 chimeric construct comprising a smooth muscle cells (SMC)-specific promoter operably linked to a muscle-specific enhancer; expression cassette comprising such a chimeric construct to control expression of a therapeutic gene
01/27/2009US7482147 polypeptides, proteins or fusion proteins having hydrolase enzyme activity, used for medical diagnosis and therapy
01/27/2009US7482143 Automated process for detecting the presence of a target nucleic acid in a sample
01/27/2009US7482141 Methods and compositions for vitamin K epoxide reductase
01/27/2009US7482137 glycosylation endproducts of polyketides, glycoproteins or polyketide-peptide substrates with microbial glycosyltransferases
01/27/2009US7482133 Catalytic domains of β(1,4)-galactosyltransferase I having altered donor and acceptor specificities, domains that promote in vitro protein folding, and methods for their use
01/27/2009US7482127 Detecting hybridization of target sequences; kits
01/27/2009US7482123 Hybridizing genomic DNA
01/27/2009US7482121 Incubating sample with probe having secondary structure that changes upon binding; nuclease cleavage; releasing signal generating fragment
01/27/2009US7482119 Solid phase methods for polynucleotide production
01/27/2009US7482117 Using presence of single nucleotide polymorphism in apopoliprotein gene sequences as diagnostic indicator of cardiovascular disorders
01/27/2009US7482116 Compositions and methods for obtaining nucleic acids from sputum
01/27/2009US7481998 Ex vivo and in vivo expression of the thrombomodulin gene for the treatment of cardiovascular and peripheral vascular diseases
01/27/2009CA2377508C Pcr primer constructs for use in an integrated signalling system
01/27/2009CA2236837C Detection of mammary tumor virus-like sequences in human breast cancer
01/27/2009CA2135644C Mutated steroid hormone receptors, methods for their use and molecular switch for gene therapy
01/22/2009WO2009012481A1 Use of bacteriophage outer membrane breaching proteins expressed in plants for the control of gram-negative bacteria
01/22/2009WO2009012420A1 Multiplexed analyses of test samples
01/22/2009WO2009012363A2 Nucleotides and aptamers containing boronic acid groups having biased binding to glycosylated proteins, and uses thereof
01/22/2009WO2009011778A1 βMETHOD FOR IDENTIFYING MODULATORS OF LRRTM1, LRRTM2 AND LRRTM4 USEFUL FOR TREATING ALZHEIMER'S DISEASE
01/22/2009WO2009011697A1 Rna oligonucleotides targeting ebv and host genes and their use for treatment of nasopharyngeal carcinomas
01/22/2009WO2009009900A1 Nucleic acid sequences for the amplification and detection of respiratory viruses
01/22/2009WO2009009830A1 Modification of lignin biosynthesis via sense suppression
01/22/2009WO2008130394A3 Array for detecting microbes
01/22/2009WO2008082519A3 Screening for cd93 (c1qrp)-associated polymorphism(s) in the diagnosis, prevention and treatment of autoimmune diseases
01/22/2009WO2008014400A8 Crohn disease susceptibility gene
01/22/2009WO2006055322A3 High arachidonic acid producing strains of yarrowia lipolytica
01/22/2009US20090025107 Polypeptides Having Organophosphorus Hydrolase Activity and Polynucleotides Encoding Same
01/22/2009US20090025106 C-terminally truncated interferon
01/22/2009US20090025100 DWF12 and Mutants Thereof
01/22/2009US20090025095 Method for Evaluating Compound Using Barlp and Substance for Regulating Eating and Body Weight
01/22/2009US20090023926 Biopolymer ionization; liquid chromatography
01/22/2009US20090023910 Applications with and Methods for Producing Selected Interstrand Cross-Links in Nucleic Acids
01/22/2009US20090023909 Blueberry red ringspot virus, sequences, promoters, and uses thereof
01/22/2009US20090023908 siRNA targeting ribosomal protein S2 (RPS2)
01/22/2009US20090023907 siRNA targeting kinesin spindle protein (KSP)
01/22/2009US20090023906 Dried oligonucleotide composition and method of producing the same
01/22/2009US20090023905 Transgenic animal model of bone mass modulation
01/22/2009US20090023901 Degradable Clostridial Toxins
01/22/2009US20090023895 Hla-binding peptide, precursor thereof, and dna fragment and recombinant vector coding for said hla-binding peptide
01/22/2009US20090023676 RNA Interference Mediated Inhibition of MAP Kinase Gene Expression or Expression of Genes Involved in MAP Kinase Pathway Using Short Interfering Nucleic Acid (SiNA)
01/22/2009US20090023675 RNA Interference Mediated Inhibition of Gene Expression Using Chemically Modified Short Interfering Nucleic Acid (siNA)
01/22/2009US20090023674 snRNA gene-like transcriptional units and uses thereof
01/22/2009US20090023672 Age-2 aptamer
01/22/2009US20090023657 Catecholamine regulated protein
01/22/2009US20090023606 Beaded and Cross-Linked Poly(Aminoalkylene)Matrix and Uses Thereof
01/22/2009US20090023602 Binding polypeptides with restricted diversity sequences
01/22/2009US20090023593 In situ cloning from pathological tissue specimens
01/22/2009US20090023221 Oligonucleotide probes useful for detection and analysis of microrna precursors
01/22/2009US20090023216 Double-Stranded Oligonucleotides
01/22/2009US20090023198 Optimizing expression of active botulinum toxin type a
01/22/2009US20090023191 Gene RCS 23
01/22/2009US20090023190 Sequence amplification with loopable primers
01/22/2009US20090023188 Using Pasteurella; genetic engineering; purified nucleic acid segments
01/22/2009US20090023185 Avidin Mutants
01/22/2009US20090023183 Method For Preparing Recombinant Peptide From Spider Venom and Analgesic Composition Containing The Peptide